Position in ATYR
as of Mar 31, 2026
· filed May 5, 2026
Position Value
$150,952
-$582 QoQ
Shares Held
193,531
-0.0% QoQ
Ownership
0.197%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2023
8 quarters on record
Voting authority
Sole 97%
Shared 0%
None 3%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bank of New York Mellon Corp holds $4,845,290,998 across 311 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,672,623 | $830,842,010 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
758,492 | $472,950,091 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,578,013 | $380,253,782 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
492,071 | $148,128,128 | |
| 5 | INSM |
INSMED Inc
|
1,312,756 | $139,966,036 | |
| 6 | MRNA |
Moderna, Inc.
|
1,701,675 | $119,168,293 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
601,056 | $112,565,759 | |
| 8 | INCY |
Incyte Corp
|
972,825 | $110,279,435 |
All Filings in ATYR
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $150,952 | 193,531 | Shares | Defined | 2026-05-05 | |
| 2025-12-31 | $151,534 | 193,532 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $144,052 | 199,798 | Shares | Defined | 2025-11-03 | |
| 2025-06-30 | $942,482 | 185,894 | Shares | Defined | 2025-08-05 | |
| 2023-12-31 | $23,160 | 16,426 | Shares | Defined | 2024-01-29 | |
| 2023-09-30 | $25,953 | 16,426 | Shares | Defined | 2023-10-24 | |
| 2023-06-30 | $35,480 | 16,426 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $75,322 | 35,868 | Shares | Defined | 2023-05-09 | |
| No filing history on record for this holder in this stock. | ||||||